Virtus Lifesci Biotech Etf Market Outlook
| BBC Etf | USD 40.75 0.01 0.02% |
About 53% of Virtus LifeSci's investor base is interested to short. The current sentiment regarding investing in Virtus LifeSci Biotech etf implies that many traders are impartial. The current market sentiment, together with Virtus LifeSci's historical and current headlines, can help investors time the market. In addition, many technical investors use Virtus LifeSci Biotech etf news signals to limit their universe of possible portfolio assets.
Comfort Level 47
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Virtus LifeSci's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Virtus LifeSci Biotech.
News SentimentNeutral | Hype SentimentNeutral | Insider SentimentWaiting |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Virtus LifeSci Biotech is 'Strong Buy'. Macroaxis provides Virtus LifeSci buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BBC positions.
Execute Virtus LifeSci Advice
The Virtus recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Virtus LifeSci Biotech. Macroaxis does not own or have any residual interests in Virtus LifeSci Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Virtus LifeSci's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details |
For the selected time horizon Virtus LifeSci Biotech has a Risk Adjusted Performance of 0.1596, Jensen Alpha of 0.4086, Total Risk Alpha of 0.2193, Sortino Ratio of 0.1719 and Treynor Ratio of 0.6173Virtus LifeSci Biotech recommendation module can be used to check and cross-verify current trade recommendation provided by analysts inspecting the etf's potential to grow using all of fundamental, technical, data market data available at the time. Please use Virtus LifeSci Biotech one year return, five year return, as well as the relationship between the Five Year Return and net asset to make buy, hold, or sell decision on Virtus LifeSci.
Virtus LifeSci Trading Alerts and Improvement Suggestions
| The fund generated five year return of -7.0% | |
| Virtus LifeSci Biotech holds 98.9% of its assets under management (AUM) in equities |
Virtus LifeSci Returns Distribution Density
The distribution of Virtus LifeSci's historical returns is an attempt to chart the uncertainty of Virtus LifeSci's future price movements. The chart of the probability distribution of Virtus LifeSci daily returns describes the distribution of returns around its average expected value. We use Virtus LifeSci Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Virtus LifeSci returns is essential to provide solid investment analysis for Virtus LifeSci.
| Mean Return | 0.48 | Value At Risk | -3.15 | Potential Upside | 4.98 | Standard Deviation | 2.53 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Virtus LifeSci historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Virtus LifeSci Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Virtus LifeSci or Virtus sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Virtus LifeSci's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Virtus etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.41 | |
β | Beta against Dow Jones | 0.76 | |
σ | Overall volatility | 2.52 | |
Ir | Information ratio | 0.15 |
Virtus LifeSci Volatility Alert
Virtus LifeSci Biotech currently demonstrates below-average downside deviation. It has Information Ratio of 0.15 and Jensen Alpha of 0.41. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Virtus LifeSci's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Virtus LifeSci's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Virtus LifeSci Fundamentals Vs Peers
Comparing Virtus LifeSci's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Virtus LifeSci's direct or indirect competition across all of the common fundamentals between Virtus LifeSci and the related equities. This way, we can detect undervalued stocks with similar characteristics as Virtus LifeSci or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of Virtus LifeSci's fundamental indicators could also be used in its relative valuation, which is a method of valuing Virtus LifeSci by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Virtus LifeSci to competition |
| Fundamentals | Virtus LifeSci | Peer Average |
| Price To Earning | 39.87 X | 3.15 X |
| Price To Book | 1.75 X | 0.39 X |
| Price To Sales | 1.99 X | 0.33 X |
| Beta | 1.59 | |
| One Year Return | 76.80 % | (0.97) % |
| Three Year Return | 14.70 % | 3.23 % |
| Five Year Return | (6.60) % | 1.12 % |
| Ten Year Return | 8.90 % | 1.20 % |
| Net Asset | 18.12 M | 2.29 B |
| Equity Positions Weight | 98.90 % | 52.82 % |
Virtus LifeSci Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Virtus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Virtus LifeSci Buy or Sell Advice
When is the right time to buy or sell Virtus LifeSci Biotech? Buying financial instruments such as Virtus Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Virtus LifeSci in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Virtus LifeSci Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Virtus LifeSci Biotech's market price often diverges from its book value, the accounting figure shown on Virtus's balance sheet. Smart investors calculate Virtus LifeSci's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Virtus LifeSci's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Virtus LifeSci's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Virtus LifeSci should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.